Neurological diseases in the context of the COVID-19 pandemic (review of the literature)
https://doi.org/10.24884/1607-4181-2020-27-2-18-24
Abstract
Currently, there is a world-wide pandemic of a new viral infection — COVID-19. The Russian Federation ranks third in the world in the number of detected cases. In the context of the current pandemic, neurological departments are reassigned to infectious diseases departments, the routing of patients is changing, and patients with neurological symptoms are less likely to seek medical help because of the fear of SARS-CoV-2 infection. At the same time, early diagnosis of neurological diseases, including acute cerebrovascular accident, becomes even more complicated, and treatment standards are not always fully applicable. This situation further emphasizes the medical and social significance of neurological diseases. There is evidence that acute cardiovascular diseases can develop as a complication of SARS-CoV-2 infection and vice versa — preexisting cardiovascular diseases aggravate the course of COVID-19. The direct and indirect effects of the virus on the central and peripheral nervous system are discussed. Cases of necrotizing encephalopathy, Guillain-Barr syndrome, a clinical picture of skeletal muscle lesions associated with the COVID-19 infection are described. This article provides an overview of the available world literature on this topic.
About the Authors
O. V. Rodionova
Pavlov University
Russian Federation
Russian Federation
Rodionova Olga V. - Cand. of Sci. (Med.), Neurologist of the Neurological Department № 1 of the Neurology Clinic of the Research Institute of Neurology, Senior Laboratory Assistant of the Department of Neurology, Pavlov University (Saint Petersburg, Russia).
6-8, L'va Tolstogo str., Saint Petersburg, 197022.
V. А. Sorokoumov
Pavlov University
Russian Federation
Russian Federation
Sorokoumov Victor А. - Dr. of Sci. (Med.), Professor of the Department of Neurology, Pavlov University.
6-8, L'va Tolstogo str., Saint Petersburg, 197022.
References
1. Kamkin E. G., Kostenko N. A., Karakulina E. V. et. al. Temporary guidelines for the prevention, diagnosis, and treatment of new coronavirus infection (COVID-19). Version 6 (28.04.2020). (In Russ.). Available at: https://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/116/original/28042020_%D0%9CR_COVID-19_v6.pdf (accessed: 12.05.2020).
2. Samorodskaya I. V., Zayratyants O. V., Perkhov V. I. et al. Trends in stroke mortality rates in Russia and the USA over a 15-year period. Archive of Pathology. 2018;2:30-37. (In Russ.).
3. Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic. Stroke. 2020;51:1910-1912. Doi: 10.1161/STROKEAHA.120.030023.
4. Martynov M. Yu., Shamalov N. A., Khasanova D. R. et al. Management of patients with acute cerebrovascular accidents in the context of the COVID-19 pandemic; temporary guidelines, Version 1 of 04.06.2020. (In Russ.). Available at: http://education.almazovcentre.ru/wp-content/uploads/2020/04/VR-Vedenie-patcientov-s-onmk-v-kontek-ste-pandemii-COVID-19.pdf (accessed: 12.05.2020).
5. Dafer R. M., Osteraas N. D., Biller J. Acute Stroke Care in the Coronavirus Disease 2019 Pandemic. Stroke Cerebrovasc Dis. 2020;29(7):104881. Doi: 10.1016/j.jstrokecerebro-vasdis.2020.104881.
6. Hugh S. M., Brainin M. COVID-19 and stroke - A global World Stroke Organization perspective. International Journal of Stroke. 2020;15(4):1-4. Doi: 10.1177/1747493020923472.
7. Fei Zhou, Ting Yu, Ronghui Du et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062. Doi: 10.1016/S0140-6736(20)30566-3.
8. Stroke: Hands. for doctors / ed. Stakhovsky L. V., Kotova S. V. Moscow, Medical Information Agency, 2014:37-38. (In Russ.).
9. Mao L., Jin H., Wang M. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. Doi: 10.1001/jamaneurol.2020.1127.
10. Li Y., Wang M., Zhou Y. et. al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Lancet. 2020. Available at: https://media.tghn.org/medialibrary/2020/06/Li_2020_Preprint_Acute_cerebrovascular_disease_COVID19.pdf (accessed: 12.05.2020).
11. Lodigiania C., Iapichinoc G., Carenzo L. et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Research. 2020;191:9-14. Doi: 10.1016/j.throm-res.2020.04.024.
12. Jecko T., Ning T., Satoshi G. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18:1023-1026. Doi: 10.1111/jth.14810.
13. Grau A. J., Buggle F., Becher H. et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology. 1998;50(1):196-203.
14. Guo T., Fan Y., Chen M. et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-818. Doi: 10.1001/jamacardio.2020.1017.
15. Oxley T. J., Mocco J., Majidi S. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382:e60. Doi: 10.1056/NEJMc2009787.
16. Odintsova D. V., Malyavin A. G., Zairatyants O. V. The predictors of pneumonia in patients with acute vascular diseases. The Russian Archives of Internal Medicine. 17;7(1):55-59. Doi: 10.20514/2226-6704-2017-7-1-55-59. (In Russ.).
17. Gerasimova M. A. Contribution of Pneumonia in Maintaining a High Mortality from Strokes and Their Conse-qunces (Literature Review). Human Ecology. 2020;2:51-57. Doi: 10.33396/1728-0869-2020-2-51-57. (In Russ.).
18. Marc D., Dominique J. F., Elodie B. et al. Human coronavirus: respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents. In: Sunit K. S., Daniel R. Neuroviral Infections: RNA Viruses and Retroviruses. Florida Boca Raton, CRC press, 2013:93-122.
19. Arabi Y. M., Balkhy H. H., Hayden F. G. et al. Middle East Respiratory Syndrome. N Engl J Med. 2017;376:584-594. Doi: 10.1056/NEJMsr1408795.
20. Saiegh F. A., Ghosh R., Leibold A. et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020; 91(8):1-3. Doi: 10.1136/jnnp-2020-323522.
21. Poyiadji N., Shahin G., Noujaim D. et al. MD COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology. 2020:296(2): E119-E120. Doi: 10.1148/radiol.2020201187.
22. Zhao H., Shen D., Zhou H. et al. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-384. Doi: 10.1016/S1474-4422(20)30109-5.
23. Shlyakhto E. V. et. al. Guidelines, algorithms for medical workers at various stages of care, checklists and standard documents developed for the period of presence and threat of further spread of a new coronavirus infection in St. Petersburg. Version 1.0 dated 04.17.2020:93-96. Available at: http://zdrav.spb.ru/media/komzdrav/documents/document/file/Brochure_COVID-19_24.04_%D1%81%D0%BE%D0%BA%D1%80.pdf (accessed: 12.05.2020).
Review
For citations:
Rodionova O.V., Sorokoumov V.А. Neurological diseases in the context of the COVID-19 pandemic (review of the literature). The Scientific Notes of the Pavlov University. 2020;27(2):18-24. (In Russ.) https://doi.org/10.24884/1607-4181-2020-27-2-18-24
Views:
1321
Email this article 